Related Experiment Video
Updated: Aug 6, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Clinical Outcomes Following PM Implantation: A 3-Year Comparative Study of Sick Sinus Syndrome and Atrioventricular
Fuat Polat1,2, Haşim Tüner3, Veysi Can4
1Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Education Research Hospital, Istanbul - Turquia.
Insights
Permanent pacemaker implantation offers similar symptom relief for sick sinus syndrome (SSS) and atrioventricular block (AVB). However, distinct cardiac remodeling patterns and mortality predictors necessitate etiology-specific follow-up strategies for pacemaker recipients.
Area of Science:
- Cardiology
- Electrophysiology
- Cardiac Imaging
Background:
- Permanent pacemaker implantation is a standard treatment for sick sinus syndrome (SSS) and atrioventricular block (AVB).
- Limited comparative data exist on long-term outcomes and cardiac remodeling between SSS and AVB after pacemaker implantation.
Purpose of the Study:
- To compare three-year clinical outcomes and cardiac structural changes in patients with SSS versus AVB post-pacemaker implantation.
- To identify distinct cardiac remodeling patterns and mortality predictors based on bradyarrhythmic etiology.
Main Methods:
- Retrospective observational study of 192 adult patients (65 SSS, 127 AVB) undergoing pacemaker implantation.
- Assessment of demographic, echocardiographic, pacemaker, and clinical data at baseline and up to three years.
- Primary outcomes included cardiac structure/function changes, symptomatic improvement, atrial fibrillation, rehospitalization, and mortality.
Main Results:
- Both SSS and AVB groups showed similar declines in left ventricular ejection fraction over three years.
- SSS patients exhibited significant left atrial and ventricular dilation with increased mitral regurgitation.
- AVB patients maintained stable chamber dimensions despite high ventricular pacing; mortality predictors differed between groups.
Conclusions:
- Sick sinus syndrome and atrioventricular block patients experience comparable symptomatic benefits and clinical outcomes after pacemaker implantation.
- Distinct cardiac remodeling patterns and differing mortality predictors underscore the need for etiology-specific follow-up strategies.
- Etiology-specific management may optimize long-term care for individuals with bradyarrhythmias requiring pacemakers.
Background:
Permanent pacemaker implantation is an established treatment for both sick sinus syndrome (SSS) and atrioventricular block (AVB), yet limited data exist comparing long-term clinical outcomes and cardiac remodeling patterns between these distinct bradyarrhythmic etiologies.
Objectives:
To compare three-year clinical outcomes and cardiac structural changes between SSS and AVB patients following permanent pacemaker implantation.
Methods:
This retrospective observational study enrolled 192 adult patients (65 SSS, 127 AVB) who underwent pacemaker implantation between January 2018 and December 2020. Demographic data, echocardiographic parameters, pacemaker-recorded data, and clinical outcomes were assessed at baseline, one month, six months, one year, and three years. Primary outcomes included changes in cardiac structure and function, symptomatic improvement, new-onset atrial fibrillation, rehospitalization, and all-cause mortality.
Results:
Both groups demonstrated significant declines in left ventricular ejection fraction over three years (SSS: 57.2±6.0% to 54.3±8.3%, p<0.001; AVB: 55.5±7.0% to 53.0±6.8%, p<0.001). Despite similar ventricular dysfunction progression, distinct remodeling patterns emerged: SSS patients exhibited significant increases in left atrial diameter (31.3 to 38.8 mm, p=0.040), left ventricular end-diastolic diameter (45.2 to 51.0 mm, p<0.001), and mitral regurgitation prevalence (26.2% to 64.6%), while AVB patients maintained stable chamber dimensions despite high ventricular pacing burden (>90%). Symptomatic improvement was comparable (SSS: 85.6% vs. AVB: 83.5%, p=0.84), as were new-onset atrial fibrillation (41.5% vs. 37.0%, p=0.54), rehospitalization (50.8% vs. 58.3%, p=0.38), and all-cause mortality (13.8% vs. 11.8%, p=0.69). Mortality predictors differed: mitral regurgitation severity in SSS versus coronary artery disease, beta-blocker therapy, and left atrial volume in AVB patients.
Conclusions:
Despite similar symptomatic benefits and clinical outcomes, SSS and AVB patients demonstrate distinct cardiac remodeling patterns and different mortality predictors, supporting the need for etiology-specific follow-up strategies in pacemaker recipients.
More Related Videos
16:40A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis I: Introduction